These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10990252)

  • 1. Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis.
    Nossent H
    J Rheumatol; 2000 Sep; 27(9):2282-3. PubMed ID: 10990252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--NSAID a possible cause?].
    Pind R
    Ugeskr Laeger; 2011 Mar; 173(11):837; author reply 837. PubMed ID: 21520672
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids?
    Raynauld JP
    J Rheumatol; 1997 Mar; 24(3):415-6. PubMed ID: 9058641
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Lopez-Diaz MJ; Piñeiro A; Garcia-Porrua C; Miranda-Filloy JA; Ollier WE; Martin J; Llorca J
    Arthritis Rheum; 2007 Feb; 57(1):125-32. PubMed ID: 17266100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis].
    Troelsen LN; Jacobsen S
    Ugeskr Laeger; 2006 Sep; 168(39):3304-8. PubMed ID: 17032593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
    Davis JM; Maradit-Kremers H; Gabriel SE
    J Rheumatol; 2005 Oct; 32(10):1856-62. PubMed ID: 16206334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Excess mortality from cardiovascular disease in patients with rheumatoid arthritis].
    Lindhardsen J; Gislason GH; Ahlehoff O; Madsen OR; Hansen PR
    Ugeskr Laeger; 2011 Jan; 173(5):343-6. PubMed ID: 21276397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid factor, smoking, and disease severity: associations with mortality in rheumatoid arthritis.
    Goodson NJ; Farragher TM; Symmons DP
    J Rheumatol; 2008 Jun; 35(6):945-9. PubMed ID: 18528946
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis.
    Dessein PH; Joffe BI; Stanwix AE
    J Rheumatol; 2003 Jul; 30(7):1403-5. PubMed ID: 12858433
    [No Abstract]   [Full Text] [Related]  

  • 11. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez A; Maradit Kremers H; Crowson CS; Ballman KV; Roger VL; Jacobsen SJ; O'Fallon WM; Gabriel SE
    Ann Rheum Dis; 2008 Jan; 67(1):64-9. PubMed ID: 17517756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
    Kung M; Störk S; Angermann CE
    Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
    Avouac J; Allanore Y
    Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prothrombotic state in rheumatoid arthritis: an additive risk factor for adverse cardiovascular events.
    Bisoendial RJ; Levi M; Tak PP; Stroes ES
    Semin Thromb Hemost; 2010 Jun; 36(4):452-7. PubMed ID: 20614397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy Insight: managing cardiovascular risk in patients with rheumatoid arthritis.
    Giles JT; Post W; Blumenthal RS; Bathon JM
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):320-9. PubMed ID: 16932711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C; Jurcuţ R; Tănăsescu C
    Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rheumatic diseases as risk factors for cardiovascular disease].
    Nurmohamed MT; Voskuyl AE; van der Horst-Bruinsma IE; Dijkmans BA
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1921-4. PubMed ID: 16999275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives.
    Kitas GD; Gabriel SE
    Ann Rheum Dis; 2011 Jan; 70(1):8-14. PubMed ID: 21109513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atherosclerosis and rheumatoid arthritis].
    Soubrier M; Dougados M
    Rev Med Interne; 2006 Feb; 27(2):125-36. PubMed ID: 16040164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk in inflammatory rheumatic diseases: loose ends and common threads.
    Farragher TM; Bruce IN
    J Rheumatol; 2006 Nov; 33(11):2105-7. PubMed ID: 17086597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.